The information presented in this paper is a description of the essential requirements for a high-quality prostate cancer service. The expert group is aware that it is not possible to propose a ‘one size fits all’ system for all countries, but urges that access to MDTs and specialised treatments is guaranteed to all patients with prostate cancer in Europe.
Prostate cancer is the second most common male cancer and has a wide variation in outcomes in Europe. It has complex diagnosis and treatment challenges, and is a major healthcare burden.
Care must only be a carried out in prostate/urology cancer units or centres that have a core multidisciplinary team (MDT) and an extended team of health professionals. Such units are far from universal in European countries.
To meet European aspirations for comprehensive cancer control, healthcare organisations must consider the requirements in this paper, paying particular attention to multidisciplinarity and patient-centred pathways from diagnosis, to treatment, to survivorship.
Read the paper here.